|
VRDN Viridian Therapeutics Inc 1590750 |
| Balance Sheet |
|
Current Assets
|
$1,081,270,000.00 |
|
Assets
|
$1,097,233,000.00 |
|
Current Liabilities
|
$63,794,000.00 |
|
Liabilities
|
$435,136,000.00 |
|
Equity
|
$662,097,000.00 |
|
Shares Out
|
113238218.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-224,978,000.00 |
|
Investing Cash Flow
|
$-153,896,000.00 |
| Market Analysis |
Market Cap
|
$2,774,336,341.00 |
|
Price
|
$24.50 |
|
BVPS
|
5.85 |
|
PB
|
4.19 |
|
EPS
|
-1.15 |
|
PS
|
2442.20 |
|
FCF
|
$-226,307,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-1.08 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
-0.90 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.00 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.34 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRDN documents filed with the SEC.
VRDN Filings
Clear
